Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-24-014727

Chief Executive Officer sold 14,683 shares at $216.50 ($3,178,815)

  • Chief Executive Officer acquired 14,683 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Farrell Michael J. Chief Executive Officer 2024-05-07 Option exercise 10b5-1 +1,176 $84.98 $99,936 441,928 D
Farrell Michael J. Chief Executive Officer 2024-05-07 Option exercise 10b5-1 +13,507 $84.98 $1,147,825 455,435 D
Farrell Michael J. Chief Executive Officer 2024-05-07 Sale 10b5-1 −14,683 $216.50 $3,178,815 440,752 D
Derivatives
Farrell Michael J. Chief Executive Officer 2024-05-07 Option exercise · ResMed Common Stock Options 10b5-1 −1,176 101,605 D
Farrell Michael J. Chief Executive Officer 2024-05-07 Option exercise · ResMed Common Stock Options 10b5-1 −13,507 88,098 D
Open-market sales · 14,683 sh · avg $216.50 · $3,178,815
Loading xslF345X05/form4.xml…